Antimüllerian Hormone as a Tool to Predict the Age at Menopause

This study aimed to assess an eligible cut-off value of anti-Müllerian hormone (AMH) to detect ovarian senescence in a group of premenopausal Greek women to evaluate the possible link between AMH-values and the severity of climacteric symptoms during a follow-up of 24 months. This study included 180 women (group A, 96 women of late reproductive stage/early perimenopause; group B, 84 women in late perimenopause). We measured AMH blood levels and assessed climacteric symptoms using the Greene scale. Log-AMH is inversely associated with postmenopausal status. The AMH cut-off of 0.012 ng/mL predicts the postmenopausal status with a sensitivity of 24.2% and specificity of 30.5%. The postmenopausal stage associated with age (OR = 1.320, 95%CI: 1.084–1.320) and AMH (values ≥ vs. <0.012 ng/mL, OR = 0.225, 95%CI: 0.098–0.529, p-value < 0.001). Moreover, the severity of vasomotor symptoms (VMS) was only associated inversely with AMH (b-coefficient = −0.272, p-value = 0.027). In conclusion, AMH levels measured in the late premenopausal period are inversely associated with the time to ovarian senescence. In contrast, AMH levels measured in the perimenopausal period are inversely associated only with the severity of VMS. Therefore, a cut-off of 0.012 ng/mL predicts menopause with low sensitivity and specificity, making it challenging to use in a clinical setting.

[1]  S. Davis,et al.  Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review , 2023, Human reproduction update.

[2]  R. Rey,et al.  Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent , 2022, Biomedicines.

[3]  E. Guallar,et al.  Low anti-Müllerian hormone levels are associated with an increased risk of incident early-onset vasomotor symptoms among premenopausal women , 2022, Scientific reports.

[4]  M. Beckmann,et al.  Does Anti-Müllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis , 2022, Journal of Ovarian Research.

[5]  Weiling Yin,et al.  The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis , 2022, BMC Endocrine Disorders.

[6]  P. Nathan,et al.  Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors. , 2022, Fertility and sterility.

[7]  F. Azizi,et al.  Does the Anti-Mullerian Hormone Decline Rate Improve the Prediction of Age at Menopause? , 2021, Frontiers in Endocrinology.

[8]  R. Punchoo,et al.  Variation in the Measurement of Anti-Müllerian Hormone – What Are the Laboratory Issues? , 2021, Frontiers in Endocrinology.

[9]  J. Karvanen,et al.  Predicting the age at natural menopause in middle-aged women , 2021, Menopause.

[10]  D. Seifer,et al.  Ethnicity/Race and Age-Specific Variations of Serum AMH in Women—A Review , 2021, Frontiers in Endocrinology.

[11]  Richard A. Anderson,et al.  Anti-Müllerian Hormone in the Diagnosis and Prediction of Premature Ovarian Insufficiency , 2020, Seminars in Reproductive Medicine.

[12]  M. Sammel,et al.  Relationship of menopausal symptoms and ovarian reserve in reproductive-aged cancer survivors , 2020, Journal of Cancer Survivorship.

[13]  P. Donahoe,et al.  Anti-Mullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. , 2020, The Journal of clinical endocrinology and metabolism.

[14]  S. Nelson,et al.  Ethnic discordance in serum anti-Müllerian hormone in healthy women: a population study from China and Europe. , 2019, Reproductive biomedicine online.

[15]  E. Vrtačnik-Bokal,et al.  The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility , 2019, Journal of Assisted Reproduction and Genetics.

[16]  W. Verschuren,et al.  Can menopause prediction be improved with multiple AMH measurements? Results from the prospective Doetinchem Cohort Study. , 2019, The Journal of clinical endocrinology and metabolism.

[17]  InterLACE Study Team.  Variations in reproductive events across life: a pooled analysis of data from 505 147 women across 10 countries. , 2019, Human reproduction.

[18]  Jack A. Taylor,et al.  Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan , 2018, bioRxiv.

[19]  B. Lawrenz,et al.  Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay , 2018, Front. Endocrinol..

[20]  T. Teunis,et al.  Does anti-Müllerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study , 2018, Climacteric : the journal of the International Menopause Society.

[21]  M. Solaymani-Dodaran,et al.  Does AMH Relate to Timing of Menopause? Results of an Individual Patient Data Meta-Analysis , 2018, The Journal of clinical endocrinology and metabolism.

[22]  J. Manson,et al.  Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study , 2018, Human reproduction.

[23]  M. Sammel,et al.  Acute Menopausal Symptoms in Young Cancer Survivors Immediately following Chemotherapy , 2018, Oncology.

[24]  M. Wellons,et al.  How well does AMH relate to the timing of menopause? Results of an individual patient data meta-analysis , 2017 .

[25]  R. Wardrop,et al.  Quantifying the intraindividual variation of antimüllerian hormone in the ovarian cycle. , 2016, Fertility and sterility.

[26]  M. Eijkemans,et al.  Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study. , 2016, Human reproduction.

[27]  G. Bentley,et al.  Hot flushes and reproductive hormone levels during the menopausal transition. , 2016, Maturitas.

[28]  B. Mol,et al.  Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review , 2016, Menopause.

[29]  S. Iliodromiti,et al.  Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. , 2015, Human reproduction update.

[30]  C. Lewis,et al.  Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women's Study. , 2015, Maturitas.

[31]  M. Eijkemans,et al.  Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study. , 2015, Human reproduction.

[32]  E. Deeks.  Elecsys® AMH Assay: A Review in Anti-Müllerian Hormone Quantification and Assessment of Ovarian Reserve , 2015, Molecular Diagnosis & Therapy.

[33]  M. Faddy,et al.  The Relationship Between Variation in Size of the Primordial Follicle Pool and Age at Natural Menopause. , 2015, The Journal of clinical endocrinology and metabolism.

[34]  M. Eijkemans,et al.  Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause. , 2014, Human reproduction.

[35]  M. Faddy,et al.  The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. , 2013, The Journal of clinical endocrinology and metabolism.

[36]  M. Faddy,et al.  Prediction of Age at Menopause from Assessment of Ovarian Reserve May Be Improved by Using Body Mass Index and Smoking Status , 2013, PloS one.

[37]  M. Solaymani-Dodaran,et al.  Modeling age at menopause using serum concentration of anti-mullerian hormone. , 2013, The Journal of clinical endocrinology and metabolism.

[38]  P. Sluss,et al.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. , 2012, The Journal of clinical endocrinology and metabolism.

[39]  Hui Lin,et al.  Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. , 2012, The Journal of clinical endocrinology and metabolism.

[40]  Nicholas A. Johnson,et al.  Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women , 2011, Human reproduction.

[41]  E. Gold.  The timing of the age at which natural menopause occurs. , 2011, Obstetrics and gynecology clinics of North America.

[42]  M. Solaymani-Dodaran,et al.  Predicting age at menopause from serum antimüllerian hormone concentration , 2011, Menopause.

[43]  M. Eijkemans,et al.  Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. , 2011, The Journal of clinical endocrinology and metabolism.

[44]  M. Yosef,et al.  Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period , 2010, Annals of the New York Academy of Sciences.

[45]  M. Solaymani-Dodaran,et al.  A single test of antimüllerian hormone in late reproductive-aged women is a good predictor of menopause , 2009, Menopause.

[46]  F. Broekmans,et al.  Relationship of serum antimüllerian hormone concentration to age at menopause. , 2008, The Journal of clinical endocrinology and metabolism.

[47]  J. Habbema,et al.  Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. , 2005, Fertility and sterility.

[48]  J. Greene.  Constructing a standard climacteric scale. , 1998, Maturitas.

[49]  M. Faddy,et al.  Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. , 1992, Human reproduction.

[50]  S. Gregorich,et al.  Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women. , 2014, Fertility and sterility.